You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
醫療器械板塊普遍隨A股同業造好 啓明、愛康及復銳醫療漲10%-15%
滬指及深成僅反覆回升0.2%,但內地醫療器械、醫藥生物、流感及病毒防治板塊升2.2%-3.9%。 本港除醫藥板塊跑贏外,醫療器械板塊也普遍造好,尤其是復銳醫療科技(01696.HK)由近九個月低位連升第二天,今天股價重越10天及20天線,最高見10.32元,現報10.18元,急漲近15%。 愛康醫療(01789.HK)終止四連跌,股價由近兩年半低位反彈高見6.28元,現報6.24元,反彈12%。啓明醫療(02500.HK)由上市低位連升第二天,今天股價重越10天及20天線(27.53元),最高見29.6元,現報28.4元,續升10%。 海吉亞醫療(06078.HK)由低位反覆回升,最高見46.35元,現報46.1元,回升7.3%。醫渡科技(02158.HK)由上市低位連升第三天,今天股價重越10天及20天線(20.83元),最高見22.15元,現報21.85元,續升7.1%。 微創醫療(00853.HK)、貝康醫療(02170.HK)及心通醫療(02160.HK)升逾3%-4%,分別高見26.85元、6.7元及4元。(sz)~
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account